myirislogo
21 November, 2024 15:25 IST
Earnings
Top Stories
Strides Pharma gets USFDA approval for Colchicine Tablets
Strides Pharma Science, (Strides), a pharmaceutical company manufacturing IP-led niche products, on March 11, announced that its stepdown wholly owned subsidiary, Strides Pharma Global Pte.,
11-Mar-2022 18:16
more...
Corporate
JK Paper Q3FY22 Review-In-line quarter, promising outlook
JK Paper (JK Paper) Q3FY22 result was in-line with our estimates on key parameters. Healthy demand and price hike supported net sales growth, while prudent cost control aided operating margin expansio
02-Feb-2022 14:32
    more...
    Ind-Ra upgrades Jindal Stainless to 'IND AA-'
    India Ratings and Research (Ind-Ra) has upgraded the long-term issuer rating assigned to Jindal Stainless (JSL) to 'IND AA-' with a stable outlook, while resolving the Rating Watch Evolving (RWE). The  02-Feb-2022 14:32
    more...
    Economy
    General
    Key highlights of Union Budget 2022-23
         Finance Minsister Nirmala Sitharaman on Tuesday presented Union Budget 2022-23. Here are the key highlights: >India Economic Growth in FY22 to be at 9.2%, says Finance Minister&  01-Feb-2022 12:07
    more...
    Sector
      
      more...
      Investing News
      Supriya Lifescience makes stellar debut; lists at 55% premium
      Supriya Lifescience, a pharma API manufacturer, made a stellar debut with 55% gains, listing at Rs 425/share against IPO price of Rs 274, amidst positive market sentiments. It has a niche product port  28-Dec-2021 14:02
      more...